Clinically Collected Lung Adenocarcinoma Whole Blood for Oncology Research

Lung Adenocarcinoma Whole Blood is collected from IRB-consented donors with a confirmed diagnosis of lung adenocarcinoma, the most common form of non-small cell lung cancer. Whole blood samples support a wide range of applications, including biomarker analysis, circulating tumor DNA detection, and immune profiling.

Product Features

• Collected from diagnosed lung adenocarcinoma donors
• Preserved with anticoagulant to maintain sample integrity
• Fresh or frozen formats available
• Custom collection and volume options offered

Donor Metadata

• Diagnosis confirmation and cancer subtype
• Demographics: age, sex, race/ethnicity
• Smoking history, mutation status, and treatment background (if available)

Applications

• Circulating tumor biomarker discovery
• Immune profiling in lung cancer
• ctDNA and CTC detection for liquid biopsy

Compliance and Quality Assurance

• IRB-approved protocols with informed consent
• Quality-controlled processing and documentation
• HIPAA-compliant donor data management

Ordering & Customization

Lung Adenocarcinoma Whole Blood is available in both fresh and cryopreserved formats. Custom donor criteria, longitudinal collections, and paired biofluids are available by contacting [email protected].